George D. Yancopoulos
2010
In 2010, George D. Yancopoulos earned a total compensation of $13.4M as Chief Scientific Officer and President, Regeneron Laboratories at Regeneron Pharmaceuticals, a 161% increase compared to previous year.
Compensation breakdown
| Bonus | $630,600 |
|---|---|
| Option Awards | $4,409,700 |
| Salary | $630,600 |
| Stock Awards | $7,657,500 |
| Other | $23,940 |
| Total | $13,352,340 |
Yancopoulos received $7.7M in stock awards, accounting for 57% of the total pay in 2010.
Yancopoulos also received $630.6K in bonus, $4.4M in option awards, $630.6K in salary and $23.9K in other compensation.
Rankings
In 2010, George D. Yancopoulos' compensation ranked 191st out of 10,439 executives tracked by ExecPay. In other words, Yancopoulos earned more than 98.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 191 out of 10,439 | 98th |
Division Manufacturing | 59 out of 3,838 | 99th |
Major group Chemicals And Allied Products | 13 out of 921 | 99th |
Industry group Drugs | 9 out of 680 | 99th |
Industry Pharmaceutical Preparations | 7 out of 481 | 99th |
Source: SEC filing on April 26, 2013.
Yancopoulos' colleagues
We found three more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2010.
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019